Bill Search

  • Introduced
    Mar 13, 2025
  • Passed House
    Mar 26, 2025
  • Passed Senate
  • Signed into Law
HB 3344
West Virginia House Bill
Did you know we offer free bill tracking in Congress and 50 states, and a great mobile app? Sign up here
Relating to the establishment of a grant program to fund the United States Food and Drug Administration’s drug development trials with ibogaine
Last Action See all actions
Senate • Apr 11, 2025: Laid over on 3rd reading 4/11/2025

Summary/Bill Text

Comments on HB 3344

Tweets

Whip Lists

Sponsors
Actions
  • Apr 11, 2025 | Senate
    • On 3rd reading
    • Deferred until foot of 2nd reading
    • Laid over on 3rd reading 4/11/2025
  • Apr 10, 2025 | Senate
    • On 2nd reading
    • Read 2nd time
    • Committee amendment adopted (Voice vote)
  • Apr 09, 2025 | Senate
    • Reported do pass
    • Immediate consideration
    • Read 1st time
  • Apr 08, 2025 | Senate
    • Reported do pass, with amendment, but first to Finance
    • To Finance
  • Mar 27, 2025 | Senate
    • Introduced in Senate
    • To Health and Human Resources then Finance
    • To Health and Human Resources
  • Mar 26, 2025 | House
    • On 3rd reading, Special Calendar
    • Read 3rd time
    • Passed House (Roll No. 198)
    • Communicated to Senate
  • Mar 25, 2025 | House
    • On 2nd reading, Special Calendar
    • Read 2nd time
  • Mar 24, 2025 | House
    • On 1st reading, Special Calendar
    • Read 1st time
  • Mar 21, 2025 | House
    • Do pass
  • Mar 18, 2025 | House
    • Markup Discussion
  • Mar 13, 2025 | House
    • Filed for introduction
    • To Health and Human Resources
    • Introduced in House
    • To House Health and Human Resources